University Hospitals Seidman Cancer Center researchers Demonstrate Veracyte’s Decipher Prostate Test Predicts Benefit from Adding Hormone Therapy to Radiation University Hospitals
Oncology Researchers Gain AI Cancer Tools in One Platform the-scientist.com
Radiation Oncology Research Points to New Possibilities in Cancer Care - UT MD Anderson Oncodaily
Giredestrant Plus Everolimus Improves PFS in ER+ Advanced Breast Cancer Targeted Oncology
"Розовый октябрь": в Киеве пройдет месячник профилактики и раннего выявления рака молочной железы Рубрика
A protein known as p53 is, of all tumor suppressors in human cancer, the most frequently altered by gene mutations. When mutations cause it to be absent or nonfunctional, its loss can allow populations of mutant cells to expand through normal tissue. Researchers have long known that loss of p53 does more than remove a…
A new review published in Science brings together growing evidence that the X and Y chromosomes do more than determine biological sex. They also shape how cells function, age and respond to disease.
Scientists at the Montreal Clinical Research Institute (IRCM), led by Université de Montréal medical professor Javier Di Noia, have shed light on a fundamental mystery in immunology: How do immune cells manage to concentrate a powerful mutagenic enzyme at precisely defined regions of DNA while largely sparing the rest…
HHS launched a multi-component effort intended to improve the speed and efficiency with which clinical trials are conducted. The series of initiatives is designed to eliminate duplication, ensure more efficient enrollment and provide patients with earlier access to promising therapies. “The goal is straightforward —…
Рак груди: пациентки в Латвии смогут анонимно задать врачам самые сложные вопросы BB.LV
Рак груди: пациентки в Латвии смогут анонимно задать врачам самые сложные вопросы BB.LV
John Sfakianos, MD, on integrating ctDNA into bladder cancer trials Urology Times
The 5 Most Impactful Phase 3 Cancer Trial Results From September 2026 Cure Today